$DNDN Company News Dendreon jumps on winning European

New Post Public Reply Private Reply Replies (0) Message Board

Jan 7, 2014 at 2:14 PM

$DNDN Company News

Dendreon jumps on winning European approval for prostate-cancer treatment 11:31 a.m. Sept. 17, 2013 - Russ Britt
Storm clouds getting darker for troubled Seattle biotech Dendreon 10:49 a.m. Aug. 23, 2013 - Russ Britt
Dendreon shares slump 16% on poor Provenge outlook 8:12 a.m. Aug. 9, 2013 - MarketWatch
In focus: Bears have another chance 8:09 p.m. Aug. 7, 2013 - Lawrence G. McMillan
As cancer drug sales struggle, Dendreon shares plunge 12:14 p.m. May 9, 2013 - Russ Britt
Analyst apologizes to clients for his call on Dendreon, stock climbs 12:00 p.m. March 7, 2013 - blogs.marketwatch.com
Four charts to watch 2:03 p.m. Feb. 7, 2013 - The Trading Deck
Synageva director bought shares for trust 1:41 p.m. Jan. 17, 2013 - Insider Monkey
Friday’s movers; Best Buy has best day in 4 years 4:47 p.m. Jan. 11, 2013 - Sue Chang
Bernstein lifts Dendreon price target to $10 7:34 a.m. Jan. 11, 2013 - Greg Morcroft
Dendreon upgraded to outperform by Bernstein 7:34 a.m. Jan. 11, 2013 - Greg Morcroft
Analyst downgrades rain on Dendreon 2:43 p.m. July 31, 2012 - Val Brickates Kennedy
Dendreon down 21% on earnings, restructuring news 9:27 a.m. July 31, 2012 - Val Brickates Kennedy
Updates, advisories and surprises 7:31 p.m. July 30, 2012 - MarketWatch
Seagate shares drop on earnings, outlook 5:33 p.m. July 30, 2012 - Wallace Witkowski
Dendreon to slash jobs amid tepid earnings 5:12 p.m. July 30, 2012 - Val Brickates Kennedy
Dendreon shares drop 18% after being unhalted 5:10 p.m. July 30, 2012 - Wallace Witkowski
Dendreon to restructure, slash 600 jobs 3:31 p.m. July 30, 2012 - Val Brickates Kennedy
Dendreon shares halted for news pending 3:13 p.m. July 30, 2012 - Laura Mandaro
Savient to slash workforce by 35% 11:08 a.m. July 9, 2012 - MarketWatch.com

BioPharma Catalyst And Investment Pick In Focus: Progenics 8:44 a.m. Today - Seeking Alpha
Is A Short Squeeze Ahead for Dendreon Corporation (DNDN)? - Tale of the Tape 8:42 a.m. Jan. 6, 2014 - Zacks.com
22 Biotech Stock Predictions for 2014 7:58 a.m. Jan. 6, 2014 - TheStreet.com
February 7th Options Now Available For Dendreon (DNDN) 11:51 a.m. Jan. 2, 2014 - TheStreet.com
Dendreon: A Cautionary Tale For Biotech Investors 10:59 a.m. Dec. 30, 2013 - Wall St. Cheat Sheet
January 2014 Options Now Available For Dendreon (DNDN) 2:05 p.m. Dec. 26, 2013 - TheStreet.com
Inovio CEO Interview: PD1/PDL1 Inhibitors, Immunotherapy And Why Investors Should Be Excited About 2014 11:30 a.m. Dec. 20, 2013 - Seeking Alpha
Reasons To Sell Immuno And Buy Northwest 2:03 p.m. Dec. 19, 2013 - Seeking Alpha
Interesting DNDN Put And Call Options For January 2014 11:27 a.m. Dec. 19, 2013 - TheStreet.com
Dendreon Is A Steal Compared To New Drug Development 1:07 p.m. Dec. 18, 2013 - Seeking Alpha
The Worst Biotech CEO of 2013 Is... 7:58 a.m. Dec. 17, 2013 - TheStreet.com
Interesting DNDN Put And Call Options For January 2014 11:13 a.m. Dec. 12, 2013 - TheStreet.com
Your Vote Counts: Who is the Worst Biotech CEO of 2013? 8:32 a.m. Dec. 12, 2013 - TheStreet.com
Dendreon: Where Things Stand Now 5:21 a.m. Dec. 9, 2013 - Seeking Alpha
DNDN January 2014 Options Begin Trading 10:53 a.m. Nov. 27, 2013 - TheStreet.com
Dendreon Has Hidden Value For The Right Buyer 2:04 p.m. Nov. 25, 2013 - Seeking Alpha
DNDN December 27th Options Begin Trading 10:56 a.m. Nov. 21, 2013 - TheStreet.com
Dendreon (DNDN) Highlighted As Today's Perilous Reversal Stock 3:33 p.m. Nov. 20, 2013 - TheStreet.com
Dendreon (DNDN) in Focus: Stock Moves 9.7% Higher - Tale of the Tape 8:30 a.m. Nov. 20, 2013 - Zacks.com
Investments On Biotech's Cutting Edge: Joseph Pantginis 4:41 p.m. Nov. 18, 2013 - Seeking Alpha

RBCC to Scout New Innovations at Biotech Showcase 4:00 a.m. Jan. 2, 2014 - BusinessWire
Market Data Ahead of the Bell: Dendreon, Stryker, Novartis, and Repros Therapeutics 8:00 a.m. Dec. 16, 2013 - PR Newswire
Clinical Studies Updates, and Stock Price Movements - Research Report on Merck, Select Medical Holdings, Galena Biopharma, Dendreon, and Echo Therapeutics 8:00 a.m. Dec. 16, 2013 - PR Newswire
RBCC Appoints New CEO to Achieve Regenerative Medicine Goals 5:00 a.m. Dec. 5, 2013 - BusinessWire
Dendreon Announces Webcast Presentation at Deutsche Bank BioFEST Conference 4:01 p.m. Nov. 26, 2013 - BusinessWire
Settlement Agreement, Presentation of Trial Results, and Stock Price Update - Research Report on Johnson & Johnson, Mettler-Toledo, Galena Biopharma, Dendreon, and Amedisys 8:00 a.m. Nov. 25, 2013 - PR Newswire
NanoString Technologies Names David W. Ghesquiere Senior Vice President, Corporate & Business Development 4:05 p.m. Nov. 20, 2013 - BusinessWire
Marketing Authorizations, Financial Results, Public Offering and Leadership Transitions - Research Report on Regeneron, Dendreon, Dyax, Techne, and ICU Medical 8:04 a.m. Nov. 15, 2013 - PR Newswire
StemCells, Inc. Appoints Greg Schiffman as Chief Financial Officer 9:00 a.m. Nov. 14, 2013 - GlobeNewswire
Under AAAResearchReports.com Microscope: Repros Therapeutics Inc., Dendreon Corp., Novartis AG, and Stryker Corp. 8:10 a.m. Nov. 13, 2013 - PR Newswire
ARIA, DNDN, HSOL and OREX added to NASDAQ Active Stock Watch List at EPR 9:29 a.m. Nov. 12, 2013 - ACCESSWIRE
Dendreon Announces Third Quarter 2013 Results 8:00 a.m. Nov. 12, 2013 - BusinessWire
RBCC Explores Promising New Breakthroughs in Regenerative Medicine 6:46 a.m. Nov. 5, 2013 - BusinessWire
SNTA, DNDN, ZGNX and NVGN added to NASDAQ Active Stock Watch List at EPR 8:58 a.m. Oct. 28, 2013 - ACCESSWIRE
Market Briefing: Emerging Growth NASDAQ Stocks in the News 2:22 p.m. Oct. 25, 2013 - PR Newswire
Quarterly Reports, Licensing Agreements, and Clinical Data - Research Report on Theravance, Dendreon, ImmunoGen, Compugen, and Acorda 7:00 a.m. Oct. 22, 2013 - PR Newswire
Early Briefing and Review: Dendreon Corp., Stryker Corp., Novartis AG, and Repros Therapeutics Inc. 7:00 a.m. Oct. 22, 2013 - PR Newswire
Mentor Capital Cancer Immunotherapy Index Up 100% in 2013 7:03 a.m. Oct. 16, 2013 - BusinessWire
Dendreon to Host Conference Call on November 12 to Announce Third Quarter Financial Results 3:30 p.m. Oct. 7, 2013 - BusinessWire
Dendreon Corporation Announces Presentation of PROVENGE(R) (sipuleucel-T) Data at the 2013 European Cancer Congress 6:30 a.m. Sept. 27, 2013 - BusinessWire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ICAC's Landmark Program Strengthens Africa's Anti-Corruption Efforts

A Bold Step Towards Integrity Corruption has long been a thorn in the side of progress for many regions, and watching the Hong Kong International Academy Against Corruption (HKIAAC) step up to the plate in Africa feels like a much-needed move. I mean, when you've got the collective wisdom of folks who've been through the wringer on these issues, you'd be wise to pay heed....

Hyliion Faces Legal Whirlwind After Stock Tumbles 19.3%

Battered by Allegations: Hyliion in Legal Crosshairs Here's a hot mess Hyliion's found itself in. Amidst allegations of deception, the stock has dropped a hefty 19.3%. For anyone keeping tabs on this one, the legal eagles over at The Law Offices of Frank R. Cruz have swooped in, announcing a class action that's got all the trimmings of your classic securities mess. The...

Ardelyx Investors Face Lawsuit Over Misleading Claims

Investors Land in Hot Water with Ardelyx Alright, folks, here we go again. New York's courtroom dramas are in full swing with Ardelyx, Inc. at center stage, and not in a good way. The DJS Law Group has rallied the troops, reminding investors caught in the storm of a class action lawsuit. Specifically, it's all about alleged violations of the Securities Exchange Act of...

Suunto Unleashes High-Tech Race 3S Watch with AI Coach

The Latest in Performance Gear: Suunto's Race 3S Nobody wants their gear to be a limitation, especially out in the wild where every step counts. Enter Suunto's Race 3S—a watch that looks to change the game for those passionate about trail running. This gadget's packed with features meant for athletes who are serious about their tech, yet light enough to make you forget...

Anita Eno: 2027's Top Trailblazing Businesswoman

Anita Eno's Well-Deserved Recognition You've got to respect a story where someone claws their way up from humble beginnings to a position of serious influence. Anita Eno, Founder and CEO of Prayers Are Answered Inc., is one of those impressive figures, recently bagging the 2027 American Business Woman of the Year title. This accolade, dished out by the American Business...

Minesto Joins Sweden-Indonesia Partnership in Energy Shift

Minesto's Big Splash in Indonesia's Energy Transition Here we go, folks. Minesto's taking the plunge into Indonesia's uncharted tidal waters under a Sweden-backed partnership. This Swedish underdog in ocean energy is ready to shake things up and ride the Indonesian currents, thanks to the Sweden-Indonesia Sustainability Partnership. Now, why should this matter to you, the...

NVIDIA GTC Unveils Fleet's New AI Device Support

Expanding the AI Frontier: Fleet Meets NVIDIA NVIDIA just pulled a major move at their GTC Berlin event, rolling out a comprehensive suite of device management for their AI hardware ecosystem through Fleet. Picture this: IT folks can now handle NVIDIA’s flagship AI gear alongside all those pesky other devices without losing their minds or sleep. From RTX PRO...

PuroClean Shines in Franchise Rankings with Global Growth

Diversifying with Property Restoration Stroll through any franchise expo and the buzzwords are all there: growth, opportunity, scalability. But in the crowded room of glittery pitches, the ones really shaking things up are those that go beyond the razzle-dazzle—brands like PuroClean that stick it to the competition with real, boots-on-the-ground expansion. The...

Plaid Eyes Data Horizons; Acorns Embraces Gen Z

Fintech's Next Frontier: Plaid's Vision You ever get the feeling some folks see further down the road than others? That's Plaid CTO Will Robinson, chatting up the NYSE folks at Money20/20. The man’s got his eyes on what he calls "making sense" of financial data—no small feat in our swamped digital world. Plaid ain't some penny stock operation, either. This is an $8...

Hengrui Pharma at ESMO 2026: Innovations in Oncology

Pushing Boundaries at ESMO 2026 If there's one place where the future of cancer treatment is being etched out, it's at forums like the ESMO Congress. This year, Hengrui Pharma is rolling in with 64 research findings hotter than a two-dollar pistol, all set to make waves in oncology. From breast to lung cancer, they're covering the lot and showcasing a blend of established...